Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Florian Büttner(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Elke Schaeffeler(German Cancer Research Center)
Cited by 30
Related Papers
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508